3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
50
Prostatic Neoplasms
25
Lung Neoplasms
17
Breast Neoplasms
16
Squamous Cell Carcinoma of Head and Neck
13
Neoplasms
9
Stomach Neoplasms
8
Neoplasm Metastasis
7
Parkinson Disease 4, Autosomal Dominant Lewy Body
6
Head and Neck Neoplasms
6
Carcinoma, Transitional Cell
6
Urinary Bladder Neoplasms
5
Triple Negative Breast Neoplasms
5
Non-Muscle Invasive Bladder Neoplasms
5
Endometrial Neoplasms
5
Carcinoma, Squamous Cell
5
Prostatic Neoplasms, Castration-Resistant
4
Oropharyngeal Neoplasms
4
Carcinoma
4
Adenocarcinoma
4
Small Cell Lung Carcinoma
3
Ovarian Neoplasms
3
Nasopharyngeal Carcinoma
3
HER2-positive Breast Cancer
3
Esophageal Squamous Cell Carcinoma
3
Anatomic Stage I Breast Cancer AJCC v8
3
Vaccinia
2
Solid Tumors
2
Sarcoma
2
Salivary Gland Neoplasms
2
Interventions
fludarabine
26
Cyclophosphamide
21
Azacitidine
20
venetoclax
18
Specimen Handling
18
fludarabine phosphate
17
Whole-Body Irradiation
14
Mycophenolic Acid
14
Melphalan
14
Busulfan
14
Biopsy
14
Tacrolimus
12
Cytarabine
12
Granulocyte Colony-Stimulating Factor
10
decitabine and cedazuridine drug combination
9
Decitabine
9
Stem Cell Transplantation
8
Sirolimus
8
Peripheral Blood Stem Cell Transplantation
8
Injections
8
Filgrastim
8
Cyclosporine
8
Thiotepa
6
ruxolitinib
5
X-Rays
5
Idarubicin
5
CPX-351
5
Magnetic Resonance Spectroscopy
4
Cladribine
4
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
Docetaxel
×
90 days
×
Clear all
No trials found.